Industry update from AusBiotech and PwC
Thursday, 03 May, 2012
AusBiotech’s CEO, Dr Anna Lavelle and PricewaterhouseCoopers’ (PwC) Partner, Craig Lawn, sat down to discuss the state of the biotechnology and life sciences sector on webcast, including the impact of the R&D Tax Credit, changes in the market for capital as well as current and emerging trends.
View the webcast here.
The video is a regular production to coincide with the quarterly release of PwC’s BioForum and the latest edition was edition 39 Q3FY12. BioForum reports on the Australian and US pharmaceutical, biotechnology and medical devices markets and the broader life sciences industry.
As well as reviewing market performance, BioForum covers initial and secondary capital raisings, clinical milestones, partnerships and mergers and acquisitions.
This edition of the webcast features:
- Reflection on the past year [4:33 MIN]
-
- Impact of R&D Tax Credit [4:49 MIN]
-
- Changes in the market for capital [3:44 MIN]
-
- Trends [6:26 MIN]
Common arthritis drug also lowers blood pressure
Scientists have known for a while that methotrexate helps with inflammation, but it may also help...
AI enables precise gene editing
A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...
Shingles vaccine may reduce risk of heart attack and stroke
Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...
